ADDICERE THERAPEUTICS
Similar Organizations
Ansan Pharmaceuticals
Ansan Pharmaceuticals is a Health Care company.
More informations about "Addicere Therapeutics"
Addicere Therapeutics - Company Profile - Tracxn
Nov 27, 2024 Addicere Therapeutics uses the platform from Alexza, called Staccato, to develop a Nicotine multi-dose device to tackle nicotine addiction by combining nicotine replacement …See details»
exv99w1 - SEC.gov
Any statement describing the expectations or beliefs of the Company or Addicere Therapeutics, Inc. is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of …See details»
ADDICERE THERAPEUTICS, INC. :: California (US) - OpenCorporates
Jan 2, 2013 Free and open company data on California (US) company ADDICERE THERAPEUTICS, INC. (company number 3307590), 2091 STIERLIN CT MOUNTAIN VIEW …See details»
Addicere Therapeutics - Crunchbase
Organization. Addicere Therapeutics . Connect to CRM . Save . Summary People Signals & News Similar Companies. Similar Companies. Edit Similar Companies Section. Companies like …See details»
Addicere Therapeutics - Company Information Addicere …
Find useful insights on Addicere Therapeutics’s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Addicere …See details»
Research programme: nicotine inhalation - Addicere Therapeutics ...
Research programme: nicotine inhalation - Addicere Therapeutics Alternative Names: Staccato-nicotine Latest Information Update: 08 Jan 2022. Price : $50 * Buy Profile. Adis is an …See details»
Addicere Therapeutics, Inc. in Broomfield CO - Company Profile
Addicere Therapeutics, Inc. Overview. Addicere Therapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California and is no longer active.This …See details»
Addicere Therapeutics - Facebook
Addicere Therapeutics - FacebookSee details»
ADDICERE THERAPEUTICS INC - BROOMFIELD, CO - Business Profile
Addicere Therapeutics Inc is located at 380 Interlocken Cres in Broomfield and has been in the business of Nonclassifiable Establishments since 2010. VERIFIED Status: UNVERIFIED. …See details»
Government of Canada Invests $92 million in adMare - BIOQuébec
Apr 15, 2022 Government of Canada advances domestic life sciences sector by supporting Canadian companies, talent, and research and development. March 30, 2022 – Vancouver, …See details»
Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines …
Jul 12, 2010 Any statement describing the expectations or beliefs of the Company or Addicere Therapeutics, Inc. is a forward-looking statement, as defined in the Private Securities Litigation …See details»
Government of Canada Invests $92 million in adMare to help …
Mar 30, 2022 adMare BioInnovations is a not-for-profit organization that works to identify and de-risk promising discoveries in health and drug technologies and provide expertise, infrastructure …See details»
adMare Launches Abdera with AbCellera as a Founding Partner
VANCOUVER, BC, Jan. 14, 2021 /CNW/ - adMare BioInnovations, Canada's global life sciences venture, is pleased to announce the launch of Abdera Therapeutics Inc. (Abdera) with …See details»
adMare Launches Abdera with AbCellera as a Founding Partner
VANCOUVER, BC, Jan. 14, 2021 /CNW/ - adMare BioInnovations, Canada's global life sciences venture, is pleased to announce the launch of Abdera Therapeutics Inc. (Abdera) with …See details»
Innovating the Canadian Biotech Sector with Joseph Mancini, …
Oct 31, 2023 One such success story is Abdera Therapeutics, a company that originated within our walls. Abdera is based in Vancouver and has made remarkable strides in developing a …See details»
Government of Canada Invests $92 Million in adMare to Help …
Mar 30, 2022 “adMare greatly appreciates the strong support the Government of Canada has shown, not only to our organization but also to Canada’s entire life sciences enterprise. The …See details»
AbCellera, adMare deliver capital and R&D boost for B.C. cancer …
Jan 21, 2021 Precision oncology company Abdera Therapeutics Inc. officially launched this month with $8 million in seed financing for its efforts to use targeted radiation treatments …See details»
adMare Launches Abdera with AbCellera as a Founding Partner
Jan 14, 2021 adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce the launch of Abdera Therapeutics Inc. (Abdera) with founding partner, AbCellera …See details»
adMare Launches Abdera with AbCellera as a Founding Partner
Jan 14, 2021 adMare BioInnovations, Canada’s global life sciences venture, is pleased to announce the launch of Abdera Therapeutics Inc. (Abdera) with founding partner, AbCellera …See details»